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Abstract Glycosaminoglycans (GAGs) are natural, linear
and negatively charged heteropolysaccharides which are inci-
dent in every mammalian tissue. They consist of repeating
disaccharide units, which are composed of either sulfated or
non-sulfated monosaccharides. Depending on tissue types,
GAGs exhibit structural heterogeneity such as the position
and degree of sulfation or within their disaccharide units com-
position being heparin, heparan sulfate, chondroitine sulfate,
dermatan sulfate, keratan sulfate, and hyaluronic acid. They
are covalently linked to a core protein (proteoglycans) or as
free chains (hyaluronan). GAGs affect cell properties and
functions either by direct interaction with cell receptors or
by sequestration of growth factors. These evidences of divert
biological roles of GAGs make their characterization at cell
and tissue levels of importance. Thus, non-invasive tech-
niques are interesting to investigate, to qualitatively and quan-
titatively characterize GAGs in vitro in order to use them as
diagnostic biomarkers and/or as therapeutic targets in several
human diseases including cancer. Infrared and Raman
microspectroscopies and imaging are sensitive enough to
differentiate and classify GAG types and subtypes in spite of
their close molecular structures. Spectroscopic markers char-
acteristic of reference GAG molecules were identified.
Beyond these investigations of the standard GAG spectral
signature, infrared and Raman spectral signatures of GAG
were searched in complex biological systems like cells. The
aim of the present review is to describe the implementation of
these complementary vibrational spectroscopy techniques,
and to discuss their potentials, advantages and disadvantages
for GAG analysis. In addition, this review presents new data
as we show for the first time GAG infrared and Raman spec-
tral signatures from conditioned media and live cells,
respectively.
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Introduction
Pathophysiological aspects of glycosaminoglycans
Glycosaminoglycans (GAGs) and proteoglycans (PGs) are
major constituents of the extracellular matrix (ECM). PGs
are present at the cell surface, in the ECM, in intracellular
granules and in basement membranes [1]. GAGs are un-
branched and negatively charged heteropolysaccharides com-
posed of repeating disaccharide units of alternating uronic
acids and N-acetylated hexosamine [2]. Most of GAGs are
covalently attached to core proteins to form PGs [3, 4].
Numbers of attached GAG side chains vary from only one
chain as decorin, a Small Leucine Rich Proteoglycan
(SLRP), to more than 100 chains as aggrecan [3]. According
to the types of monosaccharide in the repeating unit and their
sulfation, there are different major categories of GAGs:
hyaluronan (HA), dermatan sulfate (DS) and chondroitin sul-
fate (CS), heparin (HEP), heparan sulfate (HS) and keratan
sulfate (KS) [3, 5]. KS is the only GAG that loses uronic acid
and contains galactose in its disaccharide units [3]. HA is a
non-sulfated GAG devoid of a covalently bound core protein.
HA is synthesized at the extracellular surface of the plasma
membrane and plays an important role in tissue homeostasis
and cancer progression [6]. All sulfated GAGs are synthesized
at the Golgi apparatus and modified by O-sulfotransferases
[7]. The ionic properties due to the presence of carboxylate
and sulfate groups make GAG molecules able to attract water
[3]. GAGs diversity is due to the modifications in sulfation
positions and epimerization of the glucuronic acids to iduronic
acids [3]. The structure and abundance of GAG chains vary
according to the tissue. For example, lumican displays four
potential sites for the substitution by N-linked KS or oligosac-
charides situated at positions 87, 126, 159 and 251 of the
human core protein. In the cornea, lumican is a KSPG char-
acterized by a smear on immunoblots, with a molecular mass
ranging approximately from 70 to 300 kDa. In contrast, in
skin, lumican is present in the dermis in the form of a glyco-
protein (57 kDa) [8]. Proteoglycans enrolled several biologi-
cal functions. They modulate cell growth-factor activation,
regulate collagen fibrillogenesis, affect tumor cell growth
and invasion, and influence corneal transparency. As a
KSPG, lumican regulates corneal transparency [9] and stimu-
lates keratocytes migration [10]. In contrast, as a glycoprotein,
it inhibits melanoma cell migration [8]. The first known bio-
logical function of GAGs is the clinical anticoagulant role of
HEP. Numerous genetic studies on GAG biosynthetic en-
zymes revealed direct evidences of involvement of GAGs in
cell growth including transforming growth factor (TGF), and
fibroblast growth factor (FGF) signalling pathways [11].
Mutations in the genes encoding sulfotransferases and gly-
cosyltransferases enzymes caused a number of genetic disor-
ders. Sulfotransferases are responsible for the synthesis of
sulfated GAGs side chains of proteoglycans. Recently, studies
revealed that mutations in genes encoding CS and DS biosyn-
thetic enzymes cause several disorders of connective tissues
[12]. In some corneal diseases, sulfated GAGs were consid-
ered to be pathogenic factors [13]. GAGs and proteoglycans
play important roles in cancer progression, where changes in
their expression and enzymes involved in their biosynthesis
and/or degradation contribute to the cancer progression [2]. In
breast cancer, overexpression of hyaluronan synthase 2 in-
creases ErbB2-dependent signalling leading to disease pro-
gression [14], while suppression of hyaluronan synthase 2
leads to inhibition of tumorigenesis and progression of breast
cancer [15]. In addition, CSPGs were shown to activate the
extracellular signal–regulated kinase and focal adhesion ki-
nase in melanoma [16]. Decorin was demonstrated to regulate
epidermal growth factor receptor signalling, thus controlling
proliferation in melanoma [6]. Any changes in the expression
of GAGs reduce cell adhesion and increase cancer cell inva-
sion [2]. Syndecans, acting in harmony with integrins and
hyaluronan signalling through CD44 was shown to increase
cancer cell motility [17]. GAGs play a major role in metastasis
and angiogenesis. HA expression affects the metastatic poten-
tial of mouse mammary carcinoma cells [18]. Degradation of
cell-surface HS chains and matrix HSPGs by heparanase in-
crease invasion and metastasis [19]. Syndecan-1 regulates the
adhesion of cancer cells to lymphatic vessel endothelium [20].
Inhibition of perlecan expression decreases the growth of co-
lon carcinoma cells and tumor angiogenesis [21]. CS has an
antiangiogenic effect by inhibiting the migration of
transendothelial monocytes [6]. Moreover, decorin was
shown to be angiostatic due to a high-affinity binding to the
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VEGFR-2 [22]. Decorin is an antagonistic ligand for VEGFR-
2 and a 12 amino acid peptide within the leucine-rich-repeat 5
domain of decorin protein was responsible for the most avid
VEGFR-2 binding, antagonizing VEGF actions [22]. In stem
cells, GAGs and PGs are considered as specific markers of
progenitor cells [23]. In addition, they play major supportive
roles in developmental signalling and provide a sanctuary for
preservation of cell Bstemness^ as demonstrated for CSPG in
neural stem cells [24] and HSPG and CSPG in hematopoietic
precursor cells [25]. These evidences of divert biological roles
of GAGs make their characterization at cell and tissue levels
of importance. Thus, non-invasive techniques are interesting
to investigate, to qualitatively and quantitatively characterize
GAGs in vitro in order to use them as diagnostic biomarkers
and/or as therapeutic targets in several human diseases includ-
ing cancer.
Bioanalytical methods for glycosaminoglycan
characterization
GAGs display an important heterogeneity in their molecular
structure including within their uronic acid, hexosamine, and
the position of the sulfate groups. Detection and identification
of GAGs structure are crucial to understand their biological
role. Extraction of GAGs is mainly performed by enzymatic
depolymerisation with exogenous proteinase or sodium hy-
droxide [26]. Physicochemical analysis of GAGs involved
ion pairing chromatography and Mass Spectrometry (MS) ap-
plied after preincubation of the samples with specific en-
zymes. The chemical analysis of such preparations is a tedious
task involving enzymatic depolymerisation of GAG chains
with specific bacterial enzymes followed by disaccharide
analysis with Gel Permeation Chromatography (GPC)
[27], High-Performance-Liquid Chromatography (HPLC),
Ultra-Performance Liquid Chromatography (UPLC) [28],
Nuclear Magnetic Resonance (NMR) spectroscopy, Mass
Spectrometry (MS) [29], Capillary Electrophoresis (CE) [30]
and Fluorophore Assisted Carbohydrate Electrophoresis
(FACE) [31, 32].
Liquid chromatography-mass spectrometry (LC-MS) and
MS, have become widely used in analysis of GAGs without
interference by impurities in biological samples [33, 34].
Reverse-phase ion-pair (RPIP)-HPLC depends on volatile li-
pophilic ion-pairing reagents in the mobile phase to favour
analyte attachment on a hydrophobic C18 stationary phase
and evaporation in electrospraying, leading to make these
ion-pairing reagents compatible with electrospray ionization
(ESI)-MS [35, 36]. RPIP-HPLC-MS is applicable for several
analytes, ranging from unsulfated to highly sulfated GAGs
[28, 37]. RPIP-UPLC-MS provides even higher resolution,
sensitivity, efficiency and peak capacity, at high pressures
(up to 108 Pa) with columns packed with 1.7 μm particles
[38]. There are several factors affecting RPIP-HPLC-MS or
RPIP-UPLC-MS separation of GAGs, such as the concentra-
tion of ion pairing reagent, counter-ion and pH. Moreover, the
routine structural analysis of GAGs in a cell, tissue or biolog-
ical fluid sample requires multiple selective polysaccharide
lyase treatments, multiple disaccharide isolation steps, multi-
ple HPLC or UPLC columns with different mobile phases and
different ESI -MS detection methods [37].
MS is another powerful technique for structural analysis of
GAGs. Soft ionization techniques, including ESI and matrix-
assisted laser desorption/ionization (MALDI) are more dedi-
cated to the analysis of neutral oligosaccharides and their at-
tached peptide and lipid conjugates [29, 39]. MALDI time-of-
flight (TOF) MS [40, 41] and ESI-MS [42] are useful ap-
proaches for the structural analysis of GAG-derived oligosac-
charides. Both ESI-MS and MALDI-TOF-MS are convenient
for structural analysis of large polar macromolecules. NMR
spectroscopy allows determining the saccharide composition,
ring conformation, glycosidic linkage, and sulfation modality
of GAGs [43, 44]. Regrettably, this technique is very limited
due to the requirement of relatively large amounts
(milligrams) of pure GAG sample.
CE is one of the most sensitive techniques for GAGs anal-
ysis due to its resolving power, separation efficiency, short
time analysis and straightforward operation [45]. Moreover,
CE has higher compatibility with several detection methods,
such as ultraviolet (UV) spectroscopy, MS [46], NMR spec-
troscopy and Laser Induced Fluorescence Detection (LIF) [47,
48]. Currently, determination of GAG disaccharides using
CE-LIF requires separate retrievals from multiple lyase-
digestion steps, and separated analysis of HS/HP and CS/DS
in two chromatographic runs, leading to a complicated and
more time-consuming technique. However, the results from
different analyses showed inaccuracy to the calculated ratio
of HS/HP and CS/DS GAGs obtained from one sample.
Chang and collaborators used a simplified procedure to do
GAG-derived disaccharides analysis from biological source
using a single CE-LIF experiment [49].
FACE is a reliable and rapid technique to analyse unsatu-
rated disaccharides on the base of electrophoresis after deriv-
atization with a fluorophore, such as AMAC. FACE presents
the advantages of the fluorescence of AMAC for high sensi-
tivities and the possibility to analyze large number of samples
with one electrophoretic apparatus at the same time [50].
FACE is able to determine disaccharides from a very small
quantity of sample (0.05 ng). Karousou and his colleagues
demonstrated that FACE is an accurate and highly selective
for CS in biological samples and established FACE technique
can be easily used for the contemporaneous separation of CS/
DS and hyaluronan [51]. Thus, FACE analysis is a powerful
tool to characterize low quantities of different sulfated CS
disaccharides.
To better understand, the roles of GAGs in physiology and
pathophysiology, it is important to be able to determine the
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structure of GAGs from a small quantity of tissue, but even
better at the cell scale according to the cell phenotype.
Spectroscopic markers characteristic of reference GAG
molecules have been identified previously based on their
molecular structures by Raman and infrared (IR)
microspectroscopies [52, 53]. These techniques are sensitive
enough to descriminate different cell types according to their
capacity to synthetise GAGs [54]. Both IR and Raman
microspectroscopies are highly sensitive to the structure, com-
position, and environment of the molecules constituting the
studied specimen. Moreover, these biophotonic methods are
rapid, non-destructive and do not require external markers. In
terms of structural and compositional analysis, IR and Raman
spectroscopies are able to give a complete Bmolecular
fingerprint^ for GAGs in the studied sample.
Principles of vibrational spectroscopy
Infrared (IR) and Raman spectroscopies are vibrational spec-
troscopic techniques based on light -matter interactions. They
allow to probe the chemical content of all forms of matter via
transitions in their vibrational energy states. The information
obtained in the form of a spectral signature characteristic of the
state, molecular structure and composition, and environment of
the sample. These techniques are currently used to characterize
simple molecules, complex biological macromolecules (lipids,
proteins, nucleic acids, polysaccharides), and even highly com-
plex systems like cells and tissues [55]. In infrared spectrosco-
py, the sample interacts with an incident light from a polychro-
matic source comprising a set of wavelengths that span over the
mid-infrared range (2.5–25 μm). The mid- infrared source
carries the energy that exactly corresponds to the energy differ-
ences between the ground state vibrational energy levels of the
molecule. As a consequence, a molecule excited by a mid-
infrared source may absorb this energy and in this case a spe-
cific bond will start vibrating. This is the case when amolecular
vibration is infrared-active, i.e., it undergoes a change in its
dipole moment during this interaction. Infrared spectroscopy
analyses the intensity difference between the incident light
and light transmitted or reflected by the sample. The infrared
spectrum therefore displays the absorption intensity at each
frequency. This spectrum can be interpreted qualitatively via
the position of the bands, which is directly related to the fre-
quency of vibration and therefore to the chemical information,
and quantitatively via its intensity, which can be associated to
its concentration. IR spectroscopy measures the absolute fre-
quencies of vibration.
Raman spectroscopy is a scattering process that is based on
the interaction of the sample with a monochromatic source,
generally a laser. During this interaction, the molecule gains
energy and reaches a Bpolarized^ or Bvirtual^ state, which is
not energetically stable and consequently the molecule comes
down to the initial energy level by emission of photons. For a
large majority of cases, the molecule will come back to its
initial energy level, i.e., the lowest vibrational energy level
of the ground state. This gives rise to elastically scattered
photons with the same frequency as that of the incident laser.
This event is the most probable and therefore predominates
and is termed as BRayleigh scattering.^ Since one gets back
the same frequency as the incident excitation, Rayleigh light
does not carry any chemical information. A second possibility
is that the scattered light is inelastic in nature, i.e., the transi-
tion to the ground state gives rise to scattered photons that
have either gained energy (anti-Stokes Raman) or given away
some energy (Stokes Raman). In both cases, the difference
between the initial and final states gives the energy of the
vibrating bond and also corresponds to the difference in ener-
gy levels measured in IR spectroscopy (see Fig. 1). However,
it must be noted that, while in IR spectroscopy a measurement
of the absolute frequency is made, in Raman spectroscopy the
measured frequency is relative since a difference is calculated
with respect to the excitation frequency. This frequency dif-
ference is also called BRaman shift.^ The spectral information
Fig. 1 Energy diagram showing transitions involved during infrared
absorption and Raman scattering processes. Rayleigh (ordinary)
scattering is when the photon is absorbed to a higher virtual state and is
instantly scattered (emitted) elastically back to the initial state, without
any change in its frequency. The photons emitted by Raman Stokes
scattering usually have a lower frequency (red shifted) than that of the
photons absorbed and these photons are inelastically scattered,
transferring some of their energy to the molecule. The reverse is also
possible; the photons emitted have a higher frequency than the photons
absorbed (blue shifted). This is called Raman Anti-Stokes, but it is less
likely at room temperature as the majority of electrons are in the ground
state. Both Raman Stokes and anti-Stokes give the vibrational
information as the Raman shift, which is the difference between the two
vibrational energy states. The difference between the ground state and the
final state gives the vibrational energy (νvib) of the system and
corresponds to energy states measured in IR spectroscopy. The
vibrational energy νvib is related to a specific molecular vibration and to
the structure and the chemical composition of the molecules of the
samples. Double and dashed arrows represent Raman shift and
overtone respectively
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obtained with the anti-Stokes and Stokes scattering is identi-
cal, but since in the former the initial state of the molecules is
not the lowest energy level, the anti-Stokes is less intense
because the number of events involved is less. Therefore, in
spontaneous Raman measurements, spectrometers are gener-
ally designed to capture mainly the Raman Stokes signal,
while the Rayleigh and anti-Stokes scattering are rejected.
The Raman spectrum therefore displays the Stokes scattering
intensity with respect to the Raman shift. In the same way as
with IR, the position of the bands is related to the chemical
nature of the sample. Its intensity can be used in a semi-
quantitative manner.
On the other hand, a molecular vibration is said to be
Raman-active if it undergoes a change in its polarizabil-
ity during the interaction. Although the origins of the
physical phenomena are not the same (absorption for IR
and scattering for Raman), both techniques inform on
the chemical nature of the sample. They are also com-
plementary because certain vibrational modes that are
active in IR may not be active in Raman and vice-versa.
So, combining both techniques can give the full vibra-
tional signature. These signatures consist of several vi-
brational modes of molecular linkages in a molecular
group: symmetrical or antisymmetrical stretching, scis-
soring, rocking, wagging, and twisting. Depending on
the applications, lasers for Raman spectroscopy can
range from the UV to the near-infrared. UV and visible
lasers produce photons of higher frequency and can
therefore cause sample heating. Also, the Bpolarized^
state can coincide with the first excited electronic level
giving rise to fluorescence emission, which will mask
the Raman signal. Sample degradation and fluorescence
can be circumvented by increasing the excitation wave-
length to the near-infrared (less energetic photons).
State-of-the-art of application of vibrational
spectroscopy to the study of glycosaminoglycans
The first IR spectra of GAGs were published more than
50 years ago [56]. Later studies analysed the differences of
the spectra in solid-state and in aqueous solutions [57], or
with different hydration rates [58–63] or from different
species (CS from different sources of cartilage, such as
crocodile, shark, chicken, ray) [64]. Several bands were
identified by spectral comparison [65] especially those as-
sociated with sulfate vibrations [66–70] and different con-
formations of iduronate [71–74]. Prepared GAGs [70] or
GAGs present in natural, PG forms [75] were character-
ized. The evolution of molecular changes with aging was
also studied [76, 77]. More recently, the association of
chemometrics with sensitive spectroscopic microtech-
niques showed a good classification of some types of
GAGs [75–78]. These studies concerned only a particular
type of GAGs or digested molecules. The first IR spectral
signatures of GAG in complex biological systems like
cells were also recently demonstrated [54]. However, IR
microspectroscopy is limited in terms of spatial resolution
and also requires sample drying. In order to study live
cells, Raman microspectroscopy (RMS) is potentially in-
teresting to perform studies in physiological conditions.
Raman spectra of GAGs were published 38 years ago
[66]. It is highly sensitive to the structure, composition,
and environment of the molecules constituting the studied
specimen [79].
The association of spectroscopy with powerful data analyt-
ical methods gives more insight into the interpretation of the
spectral information and molecular-level phenomena. When
coupled with a microscope, vibrational microspectroscopies
become highly sensitive methods capable of probing at the
micron level, thus necessitating only small amounts of sample.
Raman and Raman optical activity of GAGs was described
[80]. RMS was used to study spectral signatures of various
mixtures of GAGs with collagens [81]. Raman spectral imag-
ing of single living cancer cells was previously described
[82–85]. Moreover, vibrational microspectroscopy was shown
to be both qualitative and semi-quantitative. Surface-enhanced
Raman scattering (SERS) was used to map glycan expression
for the identification of cancerous cells [86]. Raman SERS was
reported to be highly sensitive to detect HEP [87].
The aim of the present review is to describe the
implementation of these complementary vibrational
spectroscopies (VS) techniques and to discuss their po-
tentials, advantages and disadvantages for GAG analy-
sis. In addition, this review presents new data as we
show for the first time GAG infrared and Raman spec-
tral signatures from conditioned media and live cells
(CHO-745, CHO-WT and chondrocytes), respectively.
Vibrational spectroscopy: sample preparation
for Raman and infrared analysis
CHO-WTcell line and its mutant counterpart, CHO-745, lack-
ing xylosyltransferase associated with lowGAG synthesis and
primary culture from human chondrocytes expressing high
levels of GAGs were used in the study.
Extraction of total GAGs and quantification of sulfated
GAGs
The workflow for the extraction and quantification of sul-
fated GAGs is given in Fig. 2a . Cells underwent starvation
in growth media without serum for 24 h at 37 °C with 5 %
CO2. Then, conditioned media (CM) were collected and
were centrifuged to discard the cell debris. The collected
CM was concent rated using Vivaspin™ column
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(10,000 Da MWCO) (GE Healthcare Bio-Sciences AB,
Sweden). CM was incubated overnight with proteinase at
37 °C for a non-specific protein digestion. Proteinase di-
gestion was stopped by addition of NaCl (50nM) and in-
cubation at 100 °C for 1 min. After cooling down, the
samples were centrifuged to pellet the digested proteins.
GAGs were precipitated from the supernatant by addition
of ethanol saturated sodium acetate and incubation at 4 °C
for 3 h. Purified GAGs were centrifuged and air-dried.
Dried GAG pellets were resuspended in sterile distilled
water. A Blyscan™ assay (Biocolor, Westbury, NY,
USA) was performed to determine the concentration of
sulfated GAGs. The absorbance was measured at 656 nm
from 3 replicates for each sample.
Sample preparation for Raman microspectroscopy
The workflow for micro-Raman analysis of extracted
GAGs (Fig. 2a) involves the following steps. Three drops
of 2 μL of resuspended extracted GAGs were deposited on
CaF2 substrate and air-dried. The measurements were per-
formed with a Raman microspectrometer (Horiba
JobinYvon, Villeneuve d’Ascq, France) equipped with an
Olympus microscope (model: BX40) and a dry objective
(X100, NA = 0.9). The source was a 660 nm diode laser
(Fig. 2b). The schematic for the micro-Raman analysis of
single fixed and live cells is illustrated in Fig. 2b. At 80 %
of confluence, cells were detached and cell pellets were
collected after centrifugation. Cells were resuspended in
complete cell culture medium, seeded on CaF2 substrate
(104 cells/mL) and incubated for 2 days at 37 °C with 5 %
CO2. For fixed cells analysis, cells were fixed with 4 %
paraformaldehyde (PFA) and air-dried. For live cells, the
substrate was washed then immersed in 0.9 % NaCl solu-
tion. The Raman analysis was done by using a water-
immersion objective lens.
Sample preparation for infrared analysis
The workflow for cell and extracted GAGs preparation for
FTIR analysis is given in Fig. 3. Five μL of cell suspen-
sion (105 cells/μL) or 5 μL of re-suspended GAGs extract
(1 μg/μL) were analysed with a high-throughput screening
HTS-XT extension coupled to a Tensor 27 FTIR spectrom-
eter (Bruker Optics GmbH, Etlingen, Germany). The sam-
ples were deposited in triplicate onto a high-throughput
384-well silicon plate and air-dried (Fig. 3a). Single cells
and extracted GAGs (Fig. 3b) were analysed with an FTIR
microimaging system Spotlight 400 (Perkin Elmer,
Courtaboeuf, France). Cells (1.5 × 104 cells/mL) were
seeded on a CaF2 substrate for 48 h at 37 °C. Then, they
were fixed with 4 % PFA and air-dried. For extracted
GAGs, three drops of 2 μL were deposited on a CaF2
window and air-dried.
Vibrational spectroscopy and data acquisition
Infrared spectroscopy data acquisition
The IR acquisitions of the samples were performed in trans-
mission mode, in the spectral range 4000–400 cm−1, at a spec-
tral resolution of 4 cm−1, with 64 scans and 128 scans for
extracted GAGs and cells, respectively. Before each sample
measurement, the silicon plate background was recorded and
automatically removed from the sample signal. One spectrum
was obtained from each well. Acquisitions were performed
with the OPUS software (Version 6.0, Bruker Optics,
Germany). For FTIR imaging, the analysis was acquired in
transmission mode at a spatial resolution of 6.25 μm/pixel for
cells and at 25 μm/pixel for GAG extracts. The spectral range
4000–800 cm−1 was used at a spectral resolution of 4 cm−1.
For fixed cells and extracted GAGs, 128 scans and 16 scans
were used, respectively. Spectral images of fixed cells were
taken from the whole single cell and spectral images of GAG
samples were taken across the diameter of each dried drop.
The substrate background is automatically subtracted from the
signal. The images of single cells or GAG drops were aver-
aged and the obtained spectra were pre-processed.
Fig. 2 Workflow from conditioned media to biochemical analysis and
Raman spectral analysis (a) and from cell suspension to Raman spectral
analysis of fixed and live cells (b)
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Raman microspectroscopy data acquisition
All Raman measurements were carried out with a 660 nm
laser excitation. The spectral resolution was 4 cm−1 giving
by a grating of 950 lines/mm. For extracted GAGs, an acqui-
sition of 30 spectra per dried drop was performed in the point
mode over the 600–1750 cm−1 spectral range with an accu-
mulation time of 60s. For fixed and live cells, the acquisitions
were performed in the point mode (spatial resolution of
~1μm) from cell cytoplasms over the 600–1750 cm−1 spectral
range and an acquisition time of 45 seconds/point. For extract-
ed GAGs and fixed cells, a X100 dry objective (NA = 0.9)
was used while a X100 immersion objective (NA = 0.9) was
employed for live cells measurements.
Spectral data pre-processing and analysis
For FTIR and Raman analysis, the pre-processingwas specific
for each technique. Figure 4 shows the workflow for pre-
processing of a typical FTIR spectrum. An example is shown
for a single fixed CHO-WTcell. This was carried out with the
OPUS software (Version 6.0, Bruker Optics, Germany). Raw
spectra, initially recorded between 4000 and 750 cm−1 were
reduced to the 4000–800 cm−1 spectral window to remove the
noisy end of the spectrum. Spectra were then baseline
corrected (elastic function, 9 points), their second derivative
computed to increase spectral differences, and vector
normalised.
Figure 5 shows the workflow for pre-processing of a typi-
cal Raman spectrum. An example is shown for a single live
CHO-WT cell. This was carried out with a home-made
software using the Matlab environment (The MathWorks,
Inc., Natick, USA). Raw spectra were recorded between
600 and 1750 cm−1. Before each Raman experiment, the
following spectra were recorded to correct for instrument
and substrate contributions: dark current (measurement
without laser and objective) and optics (with laser and
objective) to estimate the noise, white light (halogen lamp)
for intensity calibration, neon lamp for frequency calibra-
tion, and finally the CaF2 window to remove substrate
contribution. Each raw Raman spectrum undergoes these
steps before smoothing with a Savistsky-Golay function
(polynom order 3 and window 9) to reduce noise, baseline
and substrate subtraction, and vector normalisation on the
whole spectral range.
After this first step, data from these two techniques
were processed with exploratory techniques like hierarchi-
cal cluster analysis (HCA) and principal component anal-
ysis (PCA). These clustering methods based on distance
calculation and variance analysis, respectively, allowed to
view, in an unsupervised way, how spectra group together.
HCA computes the Euclidian distance between the spectra
using the Ward’s algorithm. This classification allows the
combination of spectra with a minimum Euclidian distance
in the same cluster. The distance between each group gives
an estimate of the spectral difference between spectral
clusters. The result of clustering is represented in a tree
called dendrogram. PCA is a statistical analysis based on
the orthogonal transformation to convert a group of obser-
vations of possible correlated variables into a group of
linearly uncorrelated principal components (PCs). PCA is
Fig. 3 Workflow from the cell
suspension or extracted GAGs to
high-throughput FTIR spectral
analysis (a) and from single cells
or extracted GAGs to FTIR
microimaging system (b)
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an exploratory method and can be performed by singular
value decomposition of a data matrix after mean centering.
Results of a PCA are presented as a plot of PC scores or
PC loadings.
Fig. 4 Steps for pre-processing of an FTIR spectrum. Example is given for a single fixed CHO-WT cell
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Fig. 5 Steps for pre-processing of a Raman spectrum. Example is given for a single live CHO-WT cell
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Infrared and Raman microspectroscopies:
rapid and non-invasive screening techniques
distinguishing cell types exhibiting low to high levels
of GAG synthesis
In terms of structural and compositional analysis, VS is
able to give a complete Bmolecular fingerprint^ of the
studied sample, depending on their molecular structure.
We previously showed that VS such as IR and Raman
microspectroscopies are promising techniques to charac-
terize, differentiate, and classify GAGs types and sub-
types despite their close molecular structures [52]. Some
characteristic spectral regions and bands were identified
and used in combination with chemometric methods such
as HCA and PCA, to characterize standard GAGs by VS
[52, 53]. These approaches could be extremely useful for
performing quality tests on GAG samples. Moreover, VS
was shown to be both qualitative and quantitative.
Brézi l lon and col laborators [54] appl ied IR
microspectroscopy and imaging to identify in a first step
the spectroscopic signatures of GAG standards, GAG-
Collagen mixtures, and in a second step cells expressing
different levels of GAGs, both in suspensions and in
isolated single cells. Cartilage chondrocytes are the cells
with the highest capacity for GAGs synthesis. The
CHO-745 cell line, lacking xylosyl transferase, is the
only known mutant deficient in the synthesis of CS
and HS which results in a decreased amount of GAGs
in these cells, compared to the wild type CHO (CHO-
WT). We first reported on IR spectroscopy of major
types of GAGs, i.e., HA, HEP, HS, C4S, C6S, DS
and GAG-collagen mixtures. We next investigated
cellular IR spectroscopy of CHO-745, CHO-WT,
chondrocytes [54] and SK-MEL-28, dermal fibroblast
(unpublished data) in suspension and performed IR im-
aging of single cells. Spectral data were analysed by
HCA chemometric method in order to characterize these
different cell types exhibiting from low to high levels of
GAG synthesis. We identified the infrared spectral sig-
natures of standard GAGs and differentiated cell types
based on their capacity of GAG synthesis [54].
In addition to the previous study performed on fixed
cells [54], we show in the present review in Fig. 6,
CHO-745, CHO-WT, and chondrocytes CM characterized
by their ability of synthesizing GAGs from very low to
high levels. Normalized FTIR spectra of these cell types
were obtained from GAGs extracted from CM (Fig. 6a
and b) and single cell analyses (Fig. 6c and d), respective-
ly. Visually, the spectral profiles (not shown) of
chondrocytes, CHO-WT and CHO-745 were similar in
Fig. 6 Hierarchical cluster and
principal component analyses
from FTIR spectra of CM
extracted GAGs and single cells.
HCA (a) and PCA (b) analyses
from FTIR spectra of CM
extracted GAGs (n = 6) obtained
from CHO-745, CHO-WT and
chondrocytes. HCA (c) and PCA
(d) analyses from FTIR spectra of
fixed CHO-745, CHO-WT and
chondrocytes (n = 10). Red and
black triangles correspond to two
different individuals. HCA and
PCA analyses were calculated on
the second derivative of the mean
spectra of each cell type in the
spectral range 1350–900 cm−1.
All replicate spectra of the same
sample are well clustered together
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the 1800–900 cm−1 spectral range, with, however, some
minor modifications for chondrocytes in the 1350–
900 cm−1 spectral range (GAGs absorption region). The
extracted GAGs from CM and the fixed cells FTIR spectra
were analysed by the HCA analysis (Fig. 6a and c). This
method was performed on all second derivative spectra for
each single cells and for CM in the 1350–900 cm−1 spec-
tral range. The spectra of cells and CM were grouped in
the same cluster and exhibited a low degree of heteroge-
neity, indicating a good reproducibility of the measure-
ments and, therefore, a low intra-group variability
(Fig. 6a and c). The inter-group variability was sufficient-
ly high to distinguish the three cell types (Fig. 6a and c).
The dendrogram also revealed the inter-group variability
enabling to differentiate between chondrocytes and both
CHO-WT and CHO-745 at both single cells and CM
levels. The clear-cut classification using the second deriv-
ative spectra in the 1350–900 cm−1 spectral range indicat-
ed that chondrocytes differed from CHO-WT and CHO-
745 by their spectral differences in the GAGs absorption
region. Moreover, these FTIR spectra were analysed by
PCA (Fig. 6b and d). PCA analysis for single cells and
CM showed low intra-group variability in both CHO cell
types whi le higher var iabi l i ty was observed in
chondrocytes. This result might be explained at least in
part by inter-individual differences from one patient to
another one and the degree of cell differentiation. In ad-
dition, the inter-group variability was sufficiently high to
distinguish the three cell types. The PCA score plot of the
three cell types showed that the first two PCs exhibited the
highest explained variance. For CM, the PC1 carried 87 %
of the total variance and allowed clear separation of CHO-
745 and CHO-WT from chondrocytes. These results also
demonstrated that PC2, representing 12 % of the total
variance, discriminated efficiently CHO-745 and CHO-
WT. For single cells, PC1 representing 89 % of the total
variance, allowed clear separation of CHO-745 and CHO-
WT from chondrocytes. The PC2 representing 9 % of the
total variance could separate CHO-745 and CHO-WT.
Therefore, the capacity of GAG synthesis of different cell
types can be clearly delineated using HCA and PCA anal-
yses. Therefore, this methodology was demonstrated to be
a useful approach for screening and identifying cells that
exhibit the capacity for GAG synthesis. Furthermore, the
method is rapid, non-destructive, non-contact, and label-
free. Taking into account the importance of GAGs in the
biomedical field, it will be challenging, to transpose this
methodology to tissue analysis in order to identify GAG
molecules in normal tissues and during pathophysiologi-
cal conditions.
Since IR microspectroscopy is limited in spatial reso-
lution and requires sample drying, RMS is potentially
interesting to perform studies in physiological conditions.
The application of Raman spectroscopy and microscopy
within biology is rapidly increasing because it can provide
chemical and compositional information. Moreover, it
does not suffer from water interference. In addition, it
does not require extens ive sample preparat ion.
Biochemical and structural information can be obtained
without labelling [88].
Raman spectroscopy is an analytical tool for cancer
research [89]. Real-time in vivo cancer diagnosis using
Raman spectroscopy is currently developing [87, 90]. It
is now applied to the analysis of biofluids [91]. The
combination of Raman spectroscopy, which measures
molecular vibrations, and Raman optical activity, which
measures the small difference in Raman Scattering from
chiral molecules using circularly polarized light, can pro-
vide information about the structure and conformational
dynamics of biological molecules such as GAGs [80]. In
the present review, we analysed for the first time normal-
ized Raman spectra from single live cells of CHO-745,
CHO-WT, and chondrocytes. The Raman analysis was
performed at 1750–600 cm−1 spectral range. In Fig. 7,
HCA analysis showed a low degree of heterogeneity,
indicating a good reproducibility of the measurements
and, therefore, a low intra-group variability. The inter-
group variability was good enough to distinguish the
three cell types (Fig. 7). The dendrogram clearly differ-
entiated between chondrocytes and both CHO-WT and
CHO-745. PCA (not shown) demonstrated the promi-
nence of the information related to GAGs.
Fig. 7 Hierarchical cluster analysis of live cells Raman spectra. HCA
was calculated on the second derivative of the mean spectra of each cell
type in the spectral range 600–1750 cm−1. All replicate spectra of the
same sample are well clustered together
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FTIR and Raman spectroscopies are emerging analyti-
cal techniques that are complementary, straight-forward,
and easy-to-use. They allow molecular characterization
of GAG either as standards or in complex biological sys-
tems such as cells. FTIR can be used either in a high-
throughput approach for analyzing CM and fixed cell
populations or in the imaging mode, where isolated fixed
single cells can be investigated. In this case, the spectral
information obtained is a snapshot of the differentiation or
proliferation state of the cell. Thus, it is possible to ana-
lyze intra- and peri-cellular GAGs at a given time. The
FTIR spectral data allow to screen and to discriminate
cells according to their capacity of GAG synthesis. FTIR
is sensitive to the degree of sulfation of GAGs. IR
microspectroscopy of live cells is feasible but remains
challenging.
Complementary to FTIR, RMS also allows to analyze
CM and cells. However, RMS offers a better spatial res-
olution, which renders measurements in subcellular com-
partments. In addition, water being a weak scatter, inves-
tigation of live cells in physiological conditions is feasi-
ble. Thus, GAGs can be analyzed in a native conforma-
tion unaltered by chemical fixation. In a complementary
way, RMS is more sensitive to glycosidic bonds. In this
study, we have used the 660 nm excitation but other
lasers from the visible to the near-IR can be adapted to
analyze intra- and peri-cellular GAGs.
Conclusions and outlook
As succinctly reviewed here, high-throughput FTIR and
Raman spectroscopies have evolved to a point at which cells
with different capacities of GAG synthesis can be discriminat-
ed. Thus, it is possible, via the use of two different chemomet-
ric clustering approaches, to distinguish between the CHO-
WT cell line and its mutant counterpart, CHO-745, lacking
xylosyltransferase associated with low GAG synthesis. The
inter-group differences were more marked when the latter
two cell lines were compared to the primary culture from
human chondrocytes expressing high levels of GAGs.
Therefore, VS could be developed for cell screening purposes
distinguishing cell types exhibiting from low to high levels of
GAG synthesis and further for identifying GAG molecules in
tissues. Taking into account the importance of GAGs in the
biomedical field, it will be challenging and further work is
needed to transpose the methodology to tissue analysis in
order to identify GAG molecules in normal tissues and during
pathophysiological conditions. In a mid-term perspective,
in vivo RMS could be developed to search for GAG spectral
signatures in peritumoral margins of certain tumors as a mark-
er of tumor progression.
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